Haemonetics Corp reports results for the quarter ended in December - Earnings Summary

Haemonetics

08/02/2022 13:43

* Haemonetics Corp  HAE.N  reported quarterly adjusted
earnings of
84 cents​​ per share for the quarter ended in December. The mean
expectation of eight analysts for the quarter was for earnings
of 73 cents per share.
    * Revenue rose 8.1% to $259.77 million from a year ago; 
analysts
expected $266.74 million. 
    * Haemonetics Corp's reported EPS for the quarter was 45
cents​.
    * The mean earnings estimate of analysts had fallen by
about 5.8%
in the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * Haemonetics Corp shares had fallen by 11.4% this quarter.
    * The company reported quarterly net income of $23.23
million.
    * Wall Street's median 12-month price target for Haemonetics
Corp
is $70.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated February 8 at 01:43 p.m.
 ​All figures in US dollars unless otherwise stated